4
Changes in Ownership
AN2 Therapeutics, Inc. Filed Acc 0001415889-24-021199
10% owner sold 3,525,094 shares at $1.08 ($3,807,102)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2024-08-09 | Sale | −3,410,335 | $1.08 | $3,683,162 | 1,725,348 | I |
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2024-08-09 | Sale | −114,759 | $1.08 | $123,940 | 300,853 | I |
| Open-market sales · 3,525,094 sh · avg $1.08 · $3,807,102 | |||||||
Loading xslF345X05/form4-08132024_090830.xml…